Advertisement

Toxicological Evaluation of Drugs

  • Joy Cavagnaro
  • Richard M. Lewis

Abstract

All drugs have the potential to produce toxicity. The degree to which such toxicity occurs in a compound as balanced against its therapeutic activity is termed the therapeutic index. Toxicity should be clearly dissociable from efficacy. The goal of toxicity testing is therefore to determine the adverse effects of drugs in well- defined biological systems, which have their own unique susceptibility to toxicity. Once determined, these effect(s) of a drug and its metabolites are extrapolated to humans so that potential risks can be weighed against potential benefits. The ultimate objective is to evaluate the probability that a drug will not produce significant damage under specific conditions of use (Health and Welfare, Canada, 1981).

Keywords

Thymidine Kinase Good Laboratory Practice Acute Toxicity Study Chronic Study Toxicological Evaluation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Cooper, J. A., Seraci, R., and Cole, P. (1979) Describing the validity of carcinogen screening tests. Br. J. Cancer 39, 87–89.PubMedCrossRefGoogle Scholar
  2. de Serres, F. J. and Matsushima, T. (1984) Meeting report—environmental mutagenesis and carcinogenesis: Test method development, validation and utilization. Mutation Res. 130, 353–359.PubMedGoogle Scholar
  3. Dews, P. B. and Wenger, G. R. (1979) Testing for behavioral effects of agents. Neurobehav. Toxicol. 1 (suppl. 1) 119–127.PubMedGoogle Scholar
  4. Dunkel, V. C., Pienta, R.J., Sinah, A., and Traul, K. A. (1981) Comparative neoplastic transformation responses of Balb/3T3 cells, Syrian hamster embryo cells and Rayscher murine leukemia virus-infected Fischer 344 rat embrvo cells to chemical compounds. J. Natl. Can. Instx 67, 1303–1312.Google Scholar
  5. Enslein, K. (1984) Estimation of toxicological endpoints by structure- activity relationships. Pharmacol. Rev. 36, 131S–135S.PubMedGoogle Scholar
  6. Farber, E. (1982) Chemical carcinogenesis. A biological perspective. Am.J. Pathol. 106. 271–296.PubMedGoogle Scholar
  7. Federal Register (1978) Good laboratory practice for nonclinical laboratory studies. 43, 29–36.Google Scholar
  8. Hassell, J. R. and Horigan, E. A. (1982) A model developmental system for measuring teratogenic potential of compounds. Teratogen Carcinogen Mutagen. 2, 353–359.CrossRefGoogle Scholar
  9. Health and Welfare, Canada. (1981) Preclinical Toxicologic Guidelines.Google Scholar
  10. Heinze,J. E. and Poulsen, N..K. (1983) The optimal design of batteries of short-term tests for detecting carcinogens. Mutation Res. 117, 259–269.PubMedCrossRefGoogle Scholar
  11. Hollstein, M., McCann,J., Angelosanto, F., and Nichols, W. (1979) Short- term tests for carcinogens and mutagensMutation Res 65, 133–226.Google Scholar
  12. Jackson, E. M. (1983) Editorial. Are food, drugs and cosmetics different or the same? J. Toxicol. Cut. Ocular Toxicol. 2, 79–80CrossRefGoogle Scholar
  13. Jakobovits, A., Banda, M. J., and Martin, G. R. (1985) Embryonal Carcinoma-Derived Growth Factors: Specific Growth-Promoting and Differentiation-Inhibiting Activities, in Cancer Cells 3. Growth Factors and Transformation Cold Spring Harbor Laboratories, New York.Google Scholar
  14. Kolbye, A. C. (1980) Impact of Short-Term Screening Tests on Regulatory Action, in Applied Methods in Oncology vol. 3 The Predictive Value of Short-Term Screening Tests in Carcinogenicity Evaluation ( Williams, G., Kroes, R., Waaijers, H. W., and van de Poll, K. W., eds.) Elsevier North-Holland Biomedical, New York.Google Scholar
  15. Kroes, R. and Feron, V. J. (1984) General toxicity testing: Sense and non-sense, science and policy. Fund. Appl. Toxicol. 4, S298 - S308.CrossRefGoogle Scholar
  16. Loose, L. D. (1985) Immunotoxicology—1984. in The Year In Immunology 1984-1985. ( Cruse, J. M. and Lewis, R. E., Jr., eds.) Karger, Basei.Google Scholar
  17. Martin, G. R. and Evans, M. J. (1975a) Multiple differentiation of clonal teratocarcinoma stem cells following embrvoid body formation in vitro. Cell 6, 467–475.CrossRefGoogle Scholar
  18. Martin, G. R. and Evans, M. J. (1976b) Differentiation of clonal lines of teratocarcinoma cells: Formation of embrvoid bodies in vitro. Proc. Natl. Acad. Sci. 72, 1441–1445.CrossRefGoogle Scholar
  19. Miller, E. C. and Miller, J. A. (1981) Mechanisms of chemical car-cinogenesis. Cancer 47, 1055–1064.PubMedCrossRefGoogle Scholar
  20. Nardonne, R. M. and Bradlaw, J. A. (1983) Toxicity testing with in vitro svstems. I. Occular tissue culture. J. Toxicol. Cut. Ocular Toxicol. 2, 81–98.CrossRefGoogle Scholar
  21. National Toxicology Program (1984) Report of the ad hoc fxmel on chemical carcinogenesis testing and evaluation. Board of Scientific Counselors National Toxicology Program, U.S. Department of Health and Human Services Public Health Service.Google Scholar
  22. Russell, W. M. S. and Burch, R. L. (1959) The Principles of Humane Experimental Techniques. Methuen, London.Google Scholar
  23. Rowan, A. N. (1985) Perspectives on alternatives to current animal testing techniques in preclinical toxicology. Ann. Rev. Pharmacol. Toxicol. 25, 225–247.CrossRefGoogle Scholar
  24. Squire, R. A. (1984) Carcinogenicity testing and safety assessment. Fund. Appl. Toxicol. 4, S326–S334.CrossRefGoogle Scholar
  25. Tilson, H. A., Mitchell, C. L., and Cabe, P. A. (1979) Screening for neurobehavioral toxicity. The need for examples of validation of testing procedures. Neurohehav. Toxicol. 1 (suppl. 1), 137–148.Google Scholar
  26. Traina, V. M. (1983) The role of toxicology in drug research and development. Med. Res. Rev. 3, 43–72.PubMedCrossRefGoogle Scholar
  27. Williams, G. M. and Weisburger, J. H. (1983) New approaches to car-cinogen bioassay in safety evaluation and regulation of chemicals. 1st Int. Conf., Boston, Massachusetts.Google Scholar

Copyright information

© The Humana Press Inc. 1987

Authors and Affiliations

  • Joy Cavagnaro
  • Richard M. Lewis

There are no affiliations available

Personalised recommendations